1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > World Generic Markets 07 DECEMBER 2015

World Generic Markets 07 DECEMBER 2015

  • December 2015
  • -
  • Espicom Business Intelligence
  • -
  • 32 pages

Industry Trend Analysis - Eisai Expansion Highlights China's Emerging Generic Market Dominance
Industry Brief - Teligent Completes Alveda Acquisition
Industry Brief - Teva Launches Pantoprazole In Canada
Industry Brief - NOC Issued For Generic Oestradiol
Industry Brief - Sandoz Canada Launches New Lorazepam Dosage
Industry Brief - Merck To Enter Canadian Biosimilar Market
Industry Brief - Appellate Court Deals Cubicin Blow To Merck
Industry Brief - Mylan Launches Nevirapine In US
Industry Brief - Mylan Launches Glipizide In US
Industry Brief - Court Delivers Palonosetron Blow To Teva
Industry Brief - Mylan Launches Almotripan In US
Industry Brief - Sandoz' Third Biosimilar Application Accepted By The FDA
Industry Trend Analysis - Amgen A Leader In Race For Biosimilar RA Market
Industry Trend Analysis - Samsung Bioepis Set To Win EU Biosimilar Etanercept First-To-Market Race
Industry Brief - Mylan Initiates Mesalamine Patent Challenge
Industry Brief - Mylan Launches Generic Adderall
Industry Brief - Breckenridge Gains Rabeprazole Approval
Industry Trend Analysis - Hikma And Xellia Will Both Profit From Acquisition Agreement
Industry Brief - Companies Gain Dutasteride Capsule Approvals
Industry Trend Analysis - US Filing Underlines Amgen's Biosimilar Market Leader Ambitions
Industry Brief - Mylan Launches Clozapine
Industry Brief - Lannett Completes KU Acquisition
Industry Brief - Beximco Gains FDA Carvedilol Approval
Industry Brief - Fresenius Kabi Launches Dexmedetomidine
Industry Trend Analysis - Product Switching Strategy Fails But Cannot Be Ruled Out
Industry Brief - Jubilant Gains Paroxetine ANDA Approval
Industry Brief - Ajanta Launches Montelukast In US
Industry Trend Analysis - Stada's Other Key Markets Will Compensate For Continued Russia Woes
Industry Trend Analysis - Next Steps Will Be Crucial Following Mylan/Perrigo Merger Rejection
Industry Brief - Mylan Authorises USD1bn Share Repurchase Plan
Industry Trend Analysis - Spanish Generic Industry Poised To Benefit From Proposed EC SPC Waiver
Industry Brief - Consilient Health Launches Rasagiline
Industry Brief - Dr Reddy's Completes Fondaparinux Acquisition From Alchemia
Industry Trend Analysis - Teva's Presence In Japanese Generic Market Will Increase Through Takeda Partnership
Industry Brief - Samsung Bioepis' Renflexis Biosimilar Approved In South Korea
Industry Trend Analysis - HIV Agreements Pressure Other Companies To Follow Suit
Industry Brief - Teva Proposes Financing Initiatives Ahead Of Actavis Acquisition

Table Of Contents

World Generic Markets 07 DECEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

Global Febuxostat Market Research Report 2016

Global Febuxostat Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Febuxostat Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Febuxostat industry, focusing on the main regions (North America, ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.